Skip to main content
. 2017 Sep;58(11):4644–4653. doi: 10.1167/iovs.17-22075

Figure 7.

Figure 7

L253X retains minimal ability to transactivate rhodopsin promoter in the presence of NRL. Dual luciferase assays showing a dose-dependent increase in CRX transactivation activity of normal or mutant (CRX1-254) in the presence of constant amount of NRL (mean ± SEM, n = 3; **** P < 0.0001; 2-way ANOVA with Bonferroni's multiple comparisons test).